Evidence map›Paper›PMID 29264207›Full record

ReviewAsian journal of urology2017

Addressing quality of life in the patient with interstitial cystitis/bladder pain syndrome.

Vinaya Vasudevan, Robert Moldwin

2 registry-linked trialsOpen access · diamondAbstract readReview
In one paragraph

Review in Asian journal of urology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04540887 nacompletednot on this mapstarted 2021, after this paper: background citation

Investigation of Potential Therapeutic Effects of Pulsed Electromagnetic Field for the Treatment of Symptoms Associated With Interstitial Cystitis/Bladder Pain Syndrome

TypeinterventionalSponsorWake Forest University Health SciencesRan2021 to 2021Enrolled10ConditionsInterstitial Cystitis, Chronic Interstitial Cystitis, Bladder Pain SyndromeArmsPulsed Electromagnetic Field (PEMF) Therapy
NCT05149573 narecruitingnot on this mapstarted 2022, after this paper: background citation

Investigation of Non-Invasive Pulsed Electromagnetic Field (PEMF) Therapy for Female Patients With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

TypeinterventionalSponsorWake Forest University Health SciencesRan2022 to 2027Enrolled75ConditionsInterstitial Cystitis, Chronic Interstitial Cystitis, Bladder Pain SyndromeArmsPulsed Electromagnetic Field (PEMF) Device, Sham Pulsed Electromagnetic Field (PEMF) Device
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Vinaya VasudevanDepartment of Urology, The Smith Institute for Urology, Northwell Health, New Hyde Park, NY, USA.
Robert MoldwinDepartment of Urology, The Smith Institute for Urology, Northwell Health, New Hyde Park, NY, USA.
Arthur Smith Institute for Urology · USNorthwell Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a debilitating, chronic condition characterized by chronic pelvic pain, urinary urgency, and frequency and is well-known to be associated with a decrease in work productivity, emotional changes, sleep, sexual dysfunction, and mobility. Many metrics of quality of life (QoL) in this patient population have been developed; however, a unified, standardized approach to QoL in these patients has not been determined. The effects of IC/BPS and co-morbid conditions on QoL are described using current validated metrics. Next, data regarding successful treatment of IC/BPS in terms of QoL improvement are reviewed. While QoL is the single most important clinical measure of success in the treatment of patients suffering from IC/BPS, addressing QoL in this patient population remains a significant challenge, as its effects on QoL are highly variable and unable to be differentiated from the effects of comorbid conditions on QoL, including depression, poor sleep, and inability to work. Future studies will need to address treatment efficacy on the basis of IC/BPS specific QoL metrics, and multi-modal assessment and therapy to address comorbid disease will also play an important role in the future to ensure comprehensive management of these patients.

Indexed as

Chronic pelvic painInterstitial cystitisInterstitial cystitis symptom index (ICSI)King's health questionnaireO'Leary-Sant questionnairePainful bladder syndromeQuality of life

Identifiers

PMID29264207
PMCPMC5730899
OpenAlexW2558563166

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.